Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

End-of-day quote. End-of-day quote  - 07/22
3409.95 INR   +0.58%
07/23 GLAXOSMITHKLINE : Taurus Securities Limited Market Roundup
07/18 GLAXOSMITHKLINE : Glaxo's ViiV Sees Positive Results In Phase IIIb T..
07/18 GLAXOSMITHKLINE : Glaxo Gets China Approval For Cervarix Cervical Ca..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
3415(c) 3440(c) 3398(c) 3390.15(c) 3409.95 Last
4 275 3 343 4 390 3 266 2 319 Volume
-1.30% +0.73% -1.22% -0.23% +0.58% Change
More quotes
Financials ( INR)
Sales 2017 31 654 M
EBIT 2017 6 142 M
Net income 2017 5 218 M
Finance 2017 11 075 M
Yield 2017 1,70%
Sales 2018 36 390 M
EBIT 2018 7 611 M
Net income 2018 6 189 M
Finance 2018 11 839 M
Yield 2018 1,77%
P/E ratio 2017 56,34
P/E ratio 2018 46,51
EV / Sales2017 8,75x
EV / Sales2018 7,59x
Capitalization 287 914 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
07/28Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
07/23 GLAXOSMITHKLINE PHARMACEUTICALS : Taurus Securities Limited Market Roundup
07/18 GLAXOSMITHKLINE : Glaxo's ViiV Sees Positive Results In Phase IIIb Triumeq Study
07/18 GLAXOSMITHKLINE : Glaxo Gets China Approval For Cervarix Cervical Cancer Vaccine
07/15 GLAXOSMITHKLINE PHARMACEUTICALS LIMI : ex-dividend day for annual dividend
07/08 GLAXOSMITHKLINE : Glaxo, NIH team to evaluate Zika vaccine
07/04 COMS : RedstoneConnect Extends Glaxo Contract To Cover Asia Offices
07/03 GLAXOSMITHKLINE PHARMACEUTICALS : Quarterly results - glaxosmithkline pharmaceut..
06/30 GLAXOSMITHKLINE : Starts Clinical Trial On GSK3359609 Cancer Treatment
06/20 TOP NEWS : Glaxo Gets Positive Top-Line Results On COPD Treatment
06/14 GLAXOSMITHKLINE : Glaxo Vaccines Chairman Moncef Slaoui To Step Down In 2017
More news
Sector news : Pharmaceuticals - NEC
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJBAYER : 2Q 2016 -- Forecast
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
More sector news : Pharmaceuticals - NEC
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE P...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 14
Average target price 2 797  INR
Spread / Average Target -18%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Deepak Shantilal Parekh Non-Executive Chairman
Andrew Aristidou Chief Financial Officer & Executive Director
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
D. Sundaram Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMA..3.33%4 285
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.13%219 526
ROCHE HOLDING LTD.-9.62%218 832
MERCK & CO., INC.11.36%162 815
More Results